[vilmosi]

> You can't compare the US to Europe without also factoring the massive benefits European patients get from the high costs in the US

Luckily for us all the major pharmaceutical companies are public and we can can see exactly where they generate their revenue. Maybe you can show us exactly by how much the US subsidises Europe then. I suspect not by much.

[chimeracoder]

> Luckily for us all the major pharmaceutical companies are public and we can can see exactly where they generate their revenue. Maybe you can show us exactly by how much the US subsidises Europe then. I suspect not by much.

All pharmaceutical companies - including those based in Europe - derive the lion's share of their revenue from the US market, despite the US having half the population.

That's pretty obvious from the relative prices of drugs in the US versus Europe and the quantities sold, but take a look yourself if you want.

[vilmosi]

> All pharmaceutical companies - including those based in Europe - derive the lion's share of their revenue from the US market, despite the US having half the population.

Again, not true. And easily verifiable. Take Norvatis for example, one of the biggest pharmaceutical companies in the world. Europe 36%, America 34%. [0]

> That's pretty obvious from the relative prices of drugs in the US versus Europe and the quantities sold, but take a look yourself if you want.

It's not obvious at all. Drug spending is a fraction of health expenditure in the US. Just because a drug is expensive it doesn't mean that money goes to the manufacturer. There's a lot of factors involved that increase the price (for profit insurance companies taking a cut as an example) and it's true in all industries.

[0] https://www.novartis.com/investors/novartis-annual-report/no...